Glucosamine-loaded injectable hydrogel promotes autophagy and inhibits apoptosis after cartilage injury.

Apoptosis Autophagy Cartilage injury Hydrogel N-acetyl- d-glucosamine

Journal

Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 30 05 2023
revised: 31 08 2023
accepted: 04 09 2023
medline: 9 10 2023
pubmed: 9 10 2023
entrez: 9 10 2023
Statut: epublish

Résumé

The ability of cartilage to regenerate and repair is limited. N-acetyl- d-glucosamine (GlcNAc) is a nutritional supplement commonly used to activate chondrocytes. To prolong the duration of action of GlcNAc and improve its curative effect after cartilage injury, a GlcNAc thermosensitive hydrogel is prepared based on Pluronic F127 (PF127). The physicochemical properties results indicate that this hydrogel is injectable and retards the release of GlcNAc. Further, the therapeutic benefits of GlcNAc hydrogel are detected through intra-articular injection in rat specimens with cartilage injury. Behavioral experiments results indicate that the rats treated with GlcNAc hydrogel had longer step lengths, smaller foot angles and slower fall times. Compared with the sham group, the expression of Sox9 was 1.5 times and the level of collagen II was 2.4 times in the hydrogel treated group. Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining result confirmed that the GlcNAc hydrogel reduce apoptosis by about 50%. Our results of immunohistochemical staining, Western blotting assays and enzyme activity detection all suggested that GlcNAc hydrogel reduce the expression of cleaved-caspase3 and caspase8 (Compared to the sham group, the protein contents were reduced by about 50% in the GlcNAc hydrogel group). We also found that GlcNAc hydrogel activates autophagy through ERK signal pathway. The results of Western blotting indicated that GlcNAc hydrogel increase the levels of LC3B and Becline1 (hydrogel group & sham group, LC3B: 1.56 ± 0.07 & 1.00 ± 0.14; Becline1: 1.98 ± 0.07 & 1.00 ± 0.13). Whereas, the content of P62 reduced after GlcNAc hydrogel treatment, the relative level in sham group and hydrogel group are 1.00 ± 0.02 and 0.73 ± 0.06. Our results revealed that the number of P-ERK positive cells in the hydrogel group (57.36 ± 3.56%) was higher when compared with the sham (24.82 ± 2.72%). And, the ratio of P-ERK and ERK was higher than that in the sham group (1.48 ± 0.07 & 1.00 ± 0.08). The GlcNAc thermosensitive hydrogel is a promising and sustainable drug delivery system for intra-articular injection in the treatment of cartilage injury.

Identifiants

pubmed: 37809776
doi: 10.1016/j.heliyon.2023.e19879
pii: S2405-8440(23)07087-1
pmc: PMC10559277
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e19879

Informations de copyright

© 2023 The Authors.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Acta Biomater. 2017 Jul 15;57:1-25
pubmed: 28088667
Cell Physiol Biochem. 2016;40(5):883-894
pubmed: 27941314
Exp Ther Med. 2017 Oct;14(4):3137-3144
pubmed: 28912864
Adv Sci (Weinh). 2019 Jun 11;6(15):1900867
pubmed: 31406678
Mater Sci Eng C Mater Biol Appl. 2021 Jan;118:111352
pubmed: 33254972
Carbohydr Polym. 2023 Sep 1;315:121019
pubmed: 37230627
J Colloid Interface Sci. 2019 May 15;544:217-229
pubmed: 30849619
Biofabrication. 2019 Dec 23;12(1):015019
pubmed: 31783391
Toxicol Res. 2020 Oct 26;37(1):85-98
pubmed: 33489860
Tissue Eng. 2005 May-Jun;11(5-6):953-63
pubmed: 15998234
Int J Mol Sci. 2023 May 14;24(10):
pubmed: 37240090
Biomaterials. 2018 Feb;156:16-27
pubmed: 29182933
Vet Surg. 2014 Jul;43(5):612-22
pubmed: 24819506
Bioengineering (Basel). 2022 Sep 24;9(10):
pubmed: 36290470
Osteoarthritis Cartilage. 2007 Aug;15(8):946-56
pubmed: 17400483
Semin Cell Dev Biol. 2017 Feb;62:67-77
pubmed: 27422331
Acta Biomater. 2018 Jan;65:1-20
pubmed: 29128537
Int J Mol Sci. 2021 Jul 06;22(14):
pubmed: 34298867
Eur J Med Res. 2015 Oct 31;20:89
pubmed: 26520587
Biomed Eng Online. 2015 Nov 18;14:105
pubmed: 26582033
PLoS One. 2018 Dec 31;13(12):e0209747
pubmed: 30596714
J Bone Miner Res. 2017 Oct;32(10):2128-2141
pubmed: 28304100
BMC Musculoskelet Disord. 2016 Jan 13;17:21
pubmed: 26762166
Colloids Surf B Biointerfaces. 2016 Nov 1;147:360-367
pubmed: 27559996
J Mater Sci Mater Med. 2022 Oct 11;33(10):74
pubmed: 36219265
Sports Med Arthrosc Rev. 2018 Mar;26(1):31-39
pubmed: 29300225
Stem Cell Res Ther. 2020 Apr 3;11(1):143
pubmed: 32245517
Ann Rheum Dis. 2018 May;77(5):760-769
pubmed: 29436471
Tissue Eng Part A. 2016 Apr;22(7-8):689-97
pubmed: 27019285

Auteurs

Yijin Chang (Y)

School of Basic Medicine, Jinzhou Medical University, Liaoning 121000, China.

Yaguang Wang (Y)

School of Basic Medicine, Jinzhou Medical University, Liaoning 121000, China.

Jiansheng Liu (J)

School of Basic Medicine, Jinzhou Medical University, Liaoning 121000, China.

Xu Chen (X)

School of Basic Medicine, Jinzhou Medical University, Liaoning 121000, China.

Xuejing Ma (X)

School of Basic Medicine, Jinzhou Medical University, Liaoning 121000, China.

Yu Hu (Y)

School of Basic Medicine, Jinzhou Medical University, Liaoning 121000, China.

He Tian (H)

School of Basic Medicine, Jinzhou Medical University, Liaoning 121000, China.

Xiaomei Wang (X)

First Affiliated Hospital of Jinzhou Medical University, Liaoning 121000, China.

Changzheng Mu (C)

School of Basic Medicine, Jinzhou Medical University, Liaoning 121000, China.

Classifications MeSH